NASC Puts Stamp of Approval on Medterra CBD’s Line of Pet Products
Medterra CBD’s line of pet products has been approved by the National Animal Supplement Council (NASC), company officials reported in early October. The product line, which includes beef, chicken and unflavored tinctures as well as joint support pet chews, was launched earlier this year.
“To qualify for NASC membership, a company must sign a written agreement to adhere to our comprehensive quality requirements,” said Bill Bookout, president of NASC. “Medterra demonstrates their commitment to these objectives by their ‘Seed to Sale’ quality philosophy that is not just articulated, but is also evidenced in the actions of their company. We welcome Medterra as a new member that will help continue to shape the future of the cannabis industry for the benefit of companion animals.”
The announcement comes just off the heels of Medterra’s recent partnership with Chuck Latham Associates Inc. (CLA), a pet sales and marketing agency. The partnership allows Medterra’s pet products to be distributed throughout the organization’s network of retailers, manufacturers and distributors in the pet specialty, veterinary and farm stores industries.
“The missions of both the NASC and CLA are very similar to ours,” said Jason Dorfman, vice president of pet at Medterra CBD, which is headquartered in Irvine, Calif. “Providing products that are of the highest quality and backed by research are at the center of all that we do.”
In addition, Medterra recently commissioned Baylor College of Medicine to conduct clinical trials on its pet products with outpatient senior dogs suffering from arthritis to measure the efficacy of its products. The study found that 80 percent of participating dogs experienced some level of benefit, including an increase in willingness to play and run, and ease in lying and standing up after using the product.